Faithward Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Buy |
11,807
+1,316
| +13% | +$288K | 0.4% | 68 |
|
|
2025
Q1 | $2.35M | Buy |
10,491
+34
| +0.3% | +$7.61K | 0.41% | 71 |
|
|
2024
Q4 | $3.43M | Buy |
10,457
+510
| +5% | +$167K | 0.58% | 49 |
|
|
2024
Q3 | $2.99M | Sell |
9,947
-133
| -1% | -$39.9K | 0.52% | 58 |
|
|
2024
Q2 | $3.32M | Buy |
10,080
+170
| +2% | +$56K | 0.6% | 52 |
|
|
2024
Q1 | $3.92M | Buy |
9,910
+125
| +1% | +$49.5K | 0.71% | 42 |
|
|
2023
Q4 | $3.89M | Buy |
9,785
+516
| +6% | +$205K | 0.86% | 31 |
|
|
2023
Q3 | $3.13M | Sell |
9,269
-267
| -3% | -$90.3K | 0.76% | 38 |
|
|
2023
Q2 | $3.76M | Sell |
9,536
-272
| -3% | -$107K | 0.87% | 31 |
|
|
2023
Q1 | $3.53M | Sell |
9,808
-6,680
| -41% | -$2.41M | 0.8% | 29 |
|
|
2022
Q4 | $3.88M | Buy |
16,488
+3,896
| +31% | +$917K | 0.84% | 38 |
|
|
2022
Q3 | $3.1M | Sell |
12,592
-21
| -0.2% | -$5.17K | 0.73% | 45 |
|
|
2022
Q2 | $3.81M | Buy |
12,613
+444
| +4% | +$134K | 0.86% | 36 |
|
|
2022
Q1 | $5M | Buy |
12,169
+623
| +5% | +$256K | 0.97% | 33 |
|
|
2021
Q4 | $5.42M | Sell |
11,546
-1,484
| -11% | -$696K | 1.03% | 27 |
|
|
2021
Q3 | $5.53M | Sell |
13,030
-543
| -4% | -$230K | 1.07% | 24 |
|
|
2021
Q2 | $4.88M | Buy |
13,573
+2,695
| +25% | +$968K | 0.97% | 32 |
|
|
2021
Q1 | $3.07M | Buy |
+10,878
| New | +$3.07M | 0.69% | 40 |
|
|
2020
Q4 | – | Sell |
-12,924
| Closed | -$3.55M | – | 226 |
|
|
2020
Q3 | $3.55M | Buy |
+12,924
| New | +$3.55M | 0.86% | 41 |
|